BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38487678)

  • 1. Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.
    Reda S; Schwarz N; Müller J; McRae HL; Oldenburg J; Pötzsch B; Rühl H
    Res Pract Thromb Haemost; 2024 Feb; 8(2):102351. PubMed ID: 38487678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
    Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
    Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.
    Cheng Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Zhang W; Wu J
    Clin Appl Thromb Hemost; 2019; 25():1076029619877458. PubMed ID: 31608652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation.
    Rühl H; Friemann AM; Reda S; Schwarz N; Winterhagen FI; Berens C; Müller J; Oldenburg J; Pötzsch B
    J Atheroscler Thromb; 2022 Jan; 29(1):82-98. PubMed ID: 33298665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.
    Yang Y; Feng G; Yan J; Wu L; Wang F; Ding D; Wang H; Jin Q
    Clin Appl Thromb Hemost; 2022; 28():10760296221097383. PubMed ID: 35535394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia.
    Li L; Gao L; Wu X; Wu W; Ding Q; Wang X
    Clin Appl Thromb Hemost; 2020; 26():1076029620944471. PubMed ID: 32886527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation and fibrinolysis after long-duration treadmill exercise controlled by individual anaerobic threshold.
    Hilberg T; Gläser D; Reckhart C; Prasa D; Stürzebecher J; Gabriel HH
    Eur J Appl Physiol; 2003 Nov; 90(5-6):639-42. PubMed ID: 12883904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia.
    Baars JW; de Boer JP; Wagstaff J; Roem D; Eerenberg-Belmer AJ; Nauta J; Pinedo HM; Hack CE
    Br J Haematol; 1992 Oct; 82(2):295-301. PubMed ID: 1419810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term venous stasis induces fibrinolytic activation but not thrombin formation.
    Rühl H; Müller J; Wäschenbach J; Oldenburg J; Dewald O; Pötzsch B
    J Atheroscler Thromb; 2014; 21(12):1260-70. PubMed ID: 25069814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections.
    Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P
    JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.
    Jansen PM; Boermeester MA; Fischer E; de Jong IW; van der Poll T; Moldawer LL; Hack CE; Lowry SF
    Blood; 1995 Aug; 86(3):1027-34. PubMed ID: 7620156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation.
    Keragala CB; McFadyen JD; Ho H; McCutcheon FM; Liu Z; Stevens H; Monagle P; Chunilal S; Medcalf RL; Tran H
    J Thromb Haemost; 2024 Mar; 22(3):785-793. PubMed ID: 37944898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
    Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.